Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00274937 · OUTCOME

Protective Effects of Amifostine Assessed Primarily by Sialometry

Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer · Source last updated 2022-10-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
Grams of saliva
Interval / dispersion
Standard Deviation
Time frame
At study enrollment

What was measured

Weight of stimulated saliva production in grams.

Analysis population: Twenty-six patients in stratum 2 were evaluated at both study enrollment and at the end of consolidation for the weight of stimulated saliva production. This outcome measure was only collected for patients in Stratum 2.

Groups in this outcome

Stratum II

AJCC Stage IIb - IV

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Stratum II26

Reported measurements

At study Enrollment
Values in Grams of saliva · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Stratum II4.975.44Not reportedNot reportedNot reported
At end of consolidation
Values in Grams of saliva · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Stratum II3.394.71Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        5.44
        value
        4.97
    title
    At study Enrollment
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        4.71
        value
        3.39
    title
    At end of consolidation
denoms
  1. counts
    1. group Id
      OG000
      value
      26
    units
    Participants
description
Weight of stimulated saliva production in grams.
dispersion Type
Standard Deviation
groups
  1. description
    AJCC Stage IIb - IV
    id
    OG000
    title
    Stratum II
param Type
MEAN
population Description
Twenty-six patients in stratum 2 were evaluated at both study enrollment and at the end of consolidation for the weight of stimulated saliva production. This outcome measure was only collected for patients in Stratum 2.
reporting Status
POSTED
time Frame
At study enrollment
title
Protective Effects of Amifostine Assessed Primarily by Sialometry
type
SECONDARY
unit Of Measure
Grams of saliva

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice